Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma
Duletić Načinović, A., Gačić, V., Valković, T., Lučin, K., Fišić, E., Žuvić Butorac, M. ... Jonjić, N. (2016). Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma. Acta Haematologica, 136. (1), 52-61. doi: 10.1159/000444624
Duletić Načinović, Antica, et al. "Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma." Acta Haematologica, vol. 136, no. 1, 2016, pp. 52-61. https://doi.org/10.1159/000444624
Duletić Načinović, Antica, Vedrana Gačić, Toni Valković, Ksenija Lučin, Elizabeta Fišić, Marta Žuvić Butorac, Irena Seili Bekafigo and Nives Jonjić. "Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma." Acta Haematologica 136, no. 1 (2016): 52-61. https://doi.org/10.1159/000444624
Duletić Načinović, A., et al. (2016) 'Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma', Acta Haematologica, 136(1), pp. 52-61. doi: 10.1159/000444624
Duletić Načinović A, Gačić V, Valković T, Lučin K, Fišić E, Žuvić Butorac M, and sur.. Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma. Acta Haematologica [Internet]. 2016 [cited 2024 October 07];136(1):52-61. doi: 10.1159/000444624
A. Duletić Načinović, et al., "Concurrent elevations of VEGF, osteopontin and
MCP-1 serum levels are independent predictors of
survival in patients with Diffuse large B- Cell
lymphoma", Acta Haematologica, vol. 136, no. 1, pp. 52-61, 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:964701. [Accessed: 07 October 2024]